MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 74 filers reported holding MEI PHARMA INC in Q2 2019. The put-call ratio across all filers is 2.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $25,000 | +47.1% | 10,000 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $17,000 | -66.0% | 10,000 | -50.0% | 0.00% | -66.7% |
Q2 2019 | $50,000 | -18.0% | 20,000 | 0.0% | 0.01% | -18.2% |
Q1 2019 | $61,000 | +15.1% | 20,000 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $53,000 | -38.4% | 20,000 | 0.0% | 0.01% | -31.2% |
Q3 2018 | $86,000 | +8.9% | 20,000 | 0.0% | 0.02% | +6.7% |
Q2 2018 | $79,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
Artal Group S.A. | 1,000,000 | $244 | 0.01% |
Annandale Capital, LLC | 100,000 | $24 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |